Aimee S. Weisner, a director at Glaukos Corporation, filed a statement of changes in beneficial ownership on November 3, 2026, disclosing a transfer of 2,382 shares of common stock on October 30, 2026, from her direct holdings to the Saeman-Weisner Family Trust at $0 price.

Key Highlights

  • Reporting person: Aimee S. Weisner, identified as a director of Glaukos Corporation (NYSE:GKOS).
  • Transaction date: October 30, 2026, with the filing submitted November 3, 2026.
  • Transfer size: 2,382 shares of common stock disposed of from direct ownership (transaction code G) at $0, and 2,382 shares acquired indirectly through the Saeman-Weisner Family Trust at $0.
  • Direct ownership after transaction: 15,801 shares held directly by Weisner following the reported transfer.
  • Indirect ownership after transaction: 31,887 shares held indirectly through the Saeman-Weisner Family Trust following the reported transfer.
  • Additional indirect holding: 2,000 shares held indirectly through the Weisner Saeman Family Irrevocable Trust, with no transaction reported against that position.

Weisner's October 30 Share Transfer at Glaukos Corporation

According to the filing, the transaction reflects shares transferred from Weisner's direct ownership to the Saeman-Weisner Family Trust, as stated in the explanation of responses. The transfer involved 2,382 shares of Glaukos common stock and was executed at a price of $0, indicating no monetary consideration changed hands. Glaukos Corporation, headquartered in San Clemente, California, develops and commercializes ophthalmic medical devices and pharmaceutical therapies, with its common stock listed on NYSE under the ticker GKOS.

The filing records Weisner's direct beneficial ownership at 15,801 shares following the transaction, down from a figure that would have included the transferred 2,382 shares before the transfer. Indirectly, Weisner holds 31,887 shares through the Saeman-Weisner Family Trust after the acquisition into that trust, and separately holds 2,000 shares through the Weisner Saeman Family Irrevocable Trust, a position for which no transaction was reported in this filing. The filing was signed by Robert Davis as attorney-in-fact on November 3, 2026.

What Was Disclosed

The filing disclosed a gift-coded transfer of 2,382 Glaukos common shares from director Aimee S. Weisner's direct holdings to the Saeman-Weisner Family Trust on October 30, 2026, at $0 consideration, with resulting direct and indirect ownership positions also reported.